论文信息 - 3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC) - 字舞流文

3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

P. Lebrun | F. Ciardiello | J. Roh | G. Bodoky | G. Folprecht | P. Rougier | J. Raoul | J. V. Laethem | Y. Park | E. V. Cutsem | J. Laethem